Details for New Drug Application (NDA): 202962
✉ Email this page to a colleague
The generic ingredient in CHABELINA FE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 202962
Tradename: | CHABELINA FE |
Applicant: | Novast Labs |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 202962
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHABELINA FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 202962 | ANDA | Mayne Pharma Inc. | 51862-896 | 51862-896-01 | 1 BLISTER PACK in 1 PACKET (51862-896-01) / 1 KIT in 1 BLISTER PACK |
CHABELINA FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 202962 | ANDA | Mayne Pharma Inc. | 51862-896 | 51862-896-02 | 1 BLISTER PACK in 1 CARTON (51862-896-02) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG | ||||
Approval Date: | Apr 15, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription